(19)
(11) EP 3 038 616 A2

(12)

(88) Date of publication A3:
05.03.2015

(43) Date of publication:
06.07.2016 Bulletin 2016/27

(21) Application number: 14841276.0

(22) Date of filing: 26.08.2014
(51) International Patent Classification (IPC): 
A61K 31/35(2006.01)
A61P 31/12(2006.01)
A61K 38/16(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/US2014/052635
(87) International publication number:
WO 2015/031313 (05.03.2015 Gazette 2015/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 26.08.2013 US 201361869823 P

(71) Applicant: The Medicines Company
Parsippany, NJ 07054 (US)

(72) Inventors:
  • MOECK, Gregory
    St. Laurent, Québec H4L 2R3 (CA)
  • ARHIN, Francis
    Laval, Québec H7W 1S1 (CA)

(74) Representative: MacLean, Martin Robert et al
Mathys & Squire LLP
The Shard 32 London Bridge Street London SE1 9SG
The Shard 32 London Bridge Street London SE1 9SG (GB)

   


(54) METHODS FOR TREATING BACTEREMIA AND OSTEOMYELITIS USING ORITAVANCIN